NCT03062748View on ClinicalTrials.gov

Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index

Enrolling by invitationOBSERVATIONAL

Enrollment

196

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Obstructive Sleep Apnea

Trial Locations (1)

17033

Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey

All Listed Sponsors

lead

Milton S. Hershey Medical Center

OTHER